Skip to main content
Erschienen in: Acta Diabetologica 4/2014

01.08.2014 | Original Article

Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose

verfasst von: Jin-Shang Wu, Feng-Hwa Lu, Yi-Ching Yang, Shei-Hsi Chang, Ying-Hsiang Huang, Jia-Jin Jason Chen, Chih-Jen Chang

Erschienen in: Acta Diabetologica | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Impaired baroreflex sensitivity (BRS) is associated with adverse cardiovascular outcomes. There are currently no studies on BRS changes in subjects with different glycemic statuses, including normal glucose tolerance (NGT), isolated impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and newly diagnosed diabetes (NDD). The aim of this study was to investigate the effects of NDD, IGT and isolated IFG on BRS, based on a community-based data. A total of 768 subjects were classified as NGT (n = 498), isolated IFG (n = 61), IGT (n = 126) and NDD (n = 83). Spontaneous BRS was determined by the spectral α coefficient method, i.e., the square root of the ratio between the power of the RR interval and the power of systolic blood pressure in the LF frequency region (0.04–0.15 Hz) after the subjects had rested in a supine position for 5 min. Valsalva ratio was calculated as the longest RR interval after release of the Valsalva maneuver, divided by the shortest RR interval during the maneuver. As compared with NGT subjects, NDD (p = 0.039) and IGT (p = 0.041) subjects had a reduced spontaneous BRS in multivariate analysis based on analysis of covariance. NDD subjects exhibited a lower Valsalva ratio than NGT subjects (p = 0.043). However, there were no significant differences in spontaneous BRS and Valsalva ratio between subjects with isolated IFG and NGT. In conclusion, NDD and IGT subjects had an impaired BRS as compared to NGT subjects. However, reduced BRS was not apparent in subjects with isolated IFG.
Literatur
1.
Zurück zum Zitat Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793–1798PubMedCrossRef Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793–1798PubMedCrossRef
2.
Zurück zum Zitat Scheffers IJM, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne J, Engeli S, Ceral J, Eckert S, Erglis A, Narkiewicz K, Philipp T, de Leeuw PW (2010) Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 56:1254–1258PubMedCrossRef Scheffers IJM, Kroon AA, Schmidli J, Jordan J, Tordoir JJ, Mohaupt MG, Luft FC, Haller H, Menne J, Engeli S, Ceral J, Eckert S, Erglis A, Narkiewicz K, Philipp T, de Leeuw PW (2010) Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 56:1254–1258PubMedCrossRef
3.
Zurück zum Zitat Levick JR (2003) Cardiovascular receptors, reflexes and central control. In An introduction to cardiovascular physiology, 4th ed. London, Edward Arnold, pp 278–297 Levick JR (2003) Cardiovascular receptors, reflexes and central control. In An introduction to cardiovascular physiology, 4th ed. London, Edward Arnold, pp 278–297
4.
Zurück zum Zitat Parati G, Di Rienzo M, Mancia G (2000) How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18:7–19PubMedCrossRef Parati G, Di Rienzo M, Mancia G (2000) How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens 18:7–19PubMedCrossRef
5.
Zurück zum Zitat Watkins LL, Grossman P, Sherwood A (1996) Noninvasive assessment of baroreflex control in borderline hypertension: comparison with the phenylephrine method. Hypertension 28:238–243PubMedCrossRef Watkins LL, Grossman P, Sherwood A (1996) Noninvasive assessment of baroreflex control in borderline hypertension: comparison with the phenylephrine method. Hypertension 28:238–243PubMedCrossRef
6.
Zurück zum Zitat Robbe HWJ, Mulder LJM, Ruddel H, Langewitz WA, Veldman JBP, Mulder G (1987) Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10:538–543PubMedCrossRef Robbe HWJ, Mulder LJM, Ruddel H, Langewitz WA, Veldman JBP, Mulder G (1987) Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension 10:538–543PubMedCrossRef
7.
Zurück zum Zitat Lord SW, Clayton RH, Hall MC, Gray JC, Murray A, McComb JM, Kenny RA (1998) Reproducibility of three different methods of measuring baroreflex sensitivity in normal subjects. Clin Sci 95:575–581PubMedCrossRef Lord SW, Clayton RH, Hall MC, Gray JC, Murray A, McComb JM, Kenny RA (1998) Reproducibility of three different methods of measuring baroreflex sensitivity in normal subjects. Clin Sci 95:575–581PubMedCrossRef
8.
Zurück zum Zitat Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef
9.
Zurück zum Zitat Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD, Heine RJ, Nijpels G, Heethaar RM, Bouter LM (2000) Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43:561–570PubMedCrossRef Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD, Heine RJ, Nijpels G, Heethaar RM, Bouter LM (2000) Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43:561–570PubMedCrossRef
10.
Zurück zum Zitat Isak B, Oflazoglu B, Tanrıdag T, Yitmen I, Us O (2008) Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 24:563–569PubMed Isak B, Oflazoglu B, Tanrıdag T, Yitmen I, Us O (2008) Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 24:563–569PubMed
11.
Zurück zum Zitat Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, Hermányi Z, Keresztes K, Jermendy G, Tesfaye S, Kempler P (2009) Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 32:181–183PubMedCentralPubMedCrossRef Putz Z, Tabák AG, Tóth N, Istenes I, Németh N, Gandhi RA, Hermányi Z, Keresztes K, Jermendy G, Tesfaye S, Kempler P (2009) Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 32:181–183PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Watkins LL, Surwit RS, Grossman P, Sherwood A (2000) Is there a glycemic threshold for impaired autonomic control? Diabetes Care 23:826–830PubMedCrossRef Watkins LL, Surwit RS, Grossman P, Sherwood A (2000) Is there a glycemic threshold for impaired autonomic control? Diabetes Care 23:826–830PubMedCrossRef
13.
Zurück zum Zitat Chang CJ, Wu JS, Lu FH, Lee HL, Yang YC, Wen MJ (1998) Fasting plasma glucose in screening for diabetes in the Taiwanese population. Diabetes Care 21:1856–1860PubMedCrossRef Chang CJ, Wu JS, Lu FH, Lee HL, Yang YC, Wen MJ (1998) Fasting plasma glucose in screening for diabetes in the Taiwanese population. Diabetes Care 21:1856–1860PubMedCrossRef
14.
Zurück zum Zitat Rolka DB, Narayan KMV, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM (2001) Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899–1903PubMedCrossRef Rolka DB, Narayan KMV, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM (2001) Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899–1903PubMedCrossRef
15.
Zurück zum Zitat Lu FH, Yang YC, Wu JS, Wu CH, Chang CJ (1998) A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med 15:564–572PubMedCrossRef Lu FH, Yang YC, Wu JS, Wu CH, Chang CJ (1998) A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med 15:564–572PubMedCrossRef
16.
Zurück zum Zitat Huikuri HV, Makikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ (1999) Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 34:1878–1883PubMedCrossRef Huikuri HV, Makikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ (1999) Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 34:1878–1883PubMedCrossRef
17.
Zurück zum Zitat World Health Organization Expert Committee (1995) Physical status: the use and interpretation of anthropometry. Technical Report Series No. 854. Geneva, WHO, pp 427–438 World Health Organization Expert Committee (1995) Physical status: the use and interpretation of anthropometry. Technical Report Series No. 854. Geneva, WHO, pp 427–438
18.
Zurück zum Zitat Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT (1993) Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25:60–70PubMedCrossRef Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT (1993) Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25:60–70PubMedCrossRef
19.
Zurück zum Zitat American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5–S10CrossRef American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5–S10CrossRef
20.
Zurück zum Zitat Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H (1993) Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 21:866–874PubMedCrossRef Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H (1993) Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 21:866–874PubMedCrossRef
21.
Zurück zum Zitat Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 93:1043–1065CrossRef
22.
Zurück zum Zitat Spallone V, Menzinger G (1997) Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 46:S67–S76PubMedCrossRef Spallone V, Menzinger G (1997) Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 46:S67–S76PubMedCrossRef
23.
Zurück zum Zitat Lawrence IG, Weston PJ, Bennett MA, McNally PG, Burden AC, Thurston H (1997) Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabetic Med 14:82–85PubMedCrossRef Lawrence IG, Weston PJ, Bennett MA, McNally PG, Burden AC, Thurston H (1997) Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabetic Med 14:82–85PubMedCrossRef
24.
Zurück zum Zitat Ylitalo A, Airaksinen KE, Sellin L, Huikuri HV (1999) Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol 83:885–889PubMedCrossRef Ylitalo A, Airaksinen KE, Sellin L, Huikuri HV (1999) Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol 83:885–889PubMedCrossRef
25.
Zurück zum Zitat Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC (2006) Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol 47:169–1674PubMedCrossRef Chern CM, Hsu HY, Hu HH, Chen YY, Hsu LC, Chao AC (2006) Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension. J Cardiovasc Pharmacol 47:169–1674PubMedCrossRef
26.
Zurück zum Zitat Watkins PJ, Edmonds ME (1999) Diabetic autonomic failure. In: Mathias CJ, Bannister SR (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 4th edn. Oxford University Press, New York, pp 378–386 Watkins PJ, Edmonds ME (1999) Diabetic autonomic failure. In: Mathias CJ, Bannister SR (eds) Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 4th edn. Oxford University Press, New York, pp 378–386
27.
Zurück zum Zitat Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM (1995) Structural versus functional modulation of the arterial baroreflex. Hypertension 26:341–347PubMedCrossRef Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM (1995) Structural versus functional modulation of the arterial baroreflex. Hypertension 26:341–347PubMedCrossRef
28.
Zurück zum Zitat Fazan VP, Salgado HC, Barreira AA (2006) Aortic depressor nerve myelinated fibers in acute and chronic experimental diabetes. Am J Hypertens 19:153–160PubMedCrossRef Fazan VP, Salgado HC, Barreira AA (2006) Aortic depressor nerve myelinated fibers in acute and chronic experimental diabetes. Am J Hypertens 19:153–160PubMedCrossRef
29.
Zurück zum Zitat Gouty S, Regalia J, Cai F, Helke CJ (2003) Alpha-Lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats. Auton Neurosci 108:32–44PubMedCrossRef Gouty S, Regalia J, Cai F, Helke CJ (2003) Alpha-Lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats. Auton Neurosci 108:32–44PubMedCrossRef
30.
Zurück zum Zitat Kaaja RJ, Poyhonen-Alho MK (2006) Insulin resistance and sympathetic overactivity in women. J Hypertens 24:131–141PubMedCrossRef Kaaja RJ, Poyhonen-Alho MK (2006) Insulin resistance and sympathetic overactivity in women. J Hypertens 24:131–141PubMedCrossRef
31.
Zurück zum Zitat Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N (2007) Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. Obesity 15:1685–1693PubMedCrossRef Skrapari I, Tentolouris N, Perrea D, Bakoyiannis C, Papazafiropoulou A, Katsilambros N (2007) Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity. Obesity 15:1685–1693PubMedCrossRef
32.
Zurück zum Zitat Pricher MP, Freeman KL, Brooks VL (2008) Insulin in the brain increases gain of baroreflex control of heart rate and lumbar sympathetic nerve activity. Hypertension 51:514–520PubMedCrossRef Pricher MP, Freeman KL, Brooks VL (2008) Insulin in the brain increases gain of baroreflex control of heart rate and lumbar sympathetic nerve activity. Hypertension 51:514–520PubMedCrossRef
33.
Zurück zum Zitat Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759PubMedCrossRef Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753–759PubMedCrossRef
34.
Zurück zum Zitat Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26:2910–2914PubMedCrossRef Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J (2003) Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26:2910–2914PubMedCrossRef
35.
Zurück zum Zitat Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekker JM (2007) High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30:332–336PubMedCrossRef Rijkelijkhuizen JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Dekker JM (2007) High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30:332–336PubMedCrossRef
36.
Zurück zum Zitat Udupa K, Thirthalli J, Sathyaprabha TN, Kishore KR, Raju TR, Gangadhar BN (2011) Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: a prospective comparison. Asian J Psychiatr 4:100–106PubMedCrossRef Udupa K, Thirthalli J, Sathyaprabha TN, Kishore KR, Raju TR, Gangadhar BN (2011) Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: a prospective comparison. Asian J Psychiatr 4:100–106PubMedCrossRef
37.
Zurück zum Zitat Wu CS, Shau WY, Chan HY, Lee YC, Lai YJ, Lai MS (2012) Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiol Drug Saf 21:980–988PubMedCrossRef Wu CS, Shau WY, Chan HY, Lee YC, Lai YJ, Lai MS (2012) Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiol Drug Saf 21:980–988PubMedCrossRef
Metadaten
Titel
Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose
verfasst von
Jin-Shang Wu
Feng-Hwa Lu
Yi-Ching Yang
Shei-Hsi Chang
Ying-Hsiang Huang
Jia-Jin Jason Chen
Chih-Jen Chang
Publikationsdatum
01.08.2014
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 4/2014
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0548-9

Weitere Artikel der Ausgabe 4/2014

Acta Diabetologica 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.